bullish
Wuxi Biologics Placement - Well Ahead of Lock-Up, Again
375 Views04 Jan 2021 18:48
Wuxi Biologics Holdings is looking to raise up to US$1bn by selling about 2% of Wuxi Biologics (Cayman) Inc (2269 HK). This is the company's 12th placement since it listed in June 2017.
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
Zhen Zhou, Toh
APAC IPOs & Placements
- China Healthcare Weekly (Feb.5)07 Feb 2021
- Pre-IPO BeiGene - Would the IPO on the STAR Market Be the Last Hurrah?03 Feb 2021
- Wuxi Biologics Placement - Laying the Groundwork for Future Growth02 Feb 2021
- Wuxi Biologics Placement - Well Ahead of Lock-Up, Again04 Jan 2021
- FTSE China 50 Index Rebalance: Turnover Is Big, Changes Were Expected, There Are Trades To Do02 Sep 2020
- Wuxi Biologics Placement - Another One Before Lock-Up, but Just in Time for the Index Inclusion01 Sep 2020
- Wuxi Biologics Placement - This Time It's Different29 Jun 2020
x